PennyMac Financial Services
PFSI · NYSE
About PFSI
- Employees
- 5,241
- Headquarters
- Westlake Village, California
- Listed
- May 9, 2013
- Sector
- Financials
- Industry
- Financial Services
- Website
- pfsi.pennymac.com
PFSI key statistics
- Market cap
- 3.08B
- Price-earnings ratio
- 8.14
- Dividend yield
- 2.07%
- Average volume
- 698.97K
- Volume
- 189.92K
- Open price
- $59.82
- High today
- $61.31
- Low today
- $59.80
- 52 Week high
- $160.36
- 52 Week low
- $57.52
PennyMac Financial Services (PFSI) at a glance
As of Oct 20, 2026, PennyMac Financial Services (PFSI) shares are priced at $60.27, giving the company a market cap of 3.08B, a price-to-earnings ratio of 8.14 and a dividend yield of 2.07%.
Today the stock has traded between $59.80 and $61.31. The current price is 0.8% above the day's low and 1.7% below its high.
Volume so far is 189.92K shares, below the average of 698.97K shares a day.
Over the past year PennyMac Financial Services has ranged from $57.52 to $160.36, and now sits 3% of the way up that range.
PennyMac Financial Services met or beat analyst EPS estimates in 1 of the last 8 quarters. In Q2 FY26 it reported $0.41 per share against an estimate of $2.39.
The average analyst price target is $92.38, 53.3% above the current price, from 9 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy66.7%
- Hold33.3%
- Sell0.0%
- Low
- $78.78
- Now
- $60.27
- High
- $105.00
PFSI earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 1 of the last 8 quarters, by 13.9% on average.
- Q3 FY24: reported $1.30 per share against an estimate of $2.96
- Q4 FY24: reported $1.95 per share against an estimate of $3.18
- Q1 FY25: reported $1.42 per share against an estimate of $2.80
- Q2 FY25: reported $2.54 per share against an estimate of $2.92
- Q3 FY25: reported $3.37 per share against an estimate of $2.96
- Q4 FY25: reported $1.97 per share against an estimate of $3.30
- Q1 FY26: reported $1.53 per share against an estimate of $2.49
- Q2 FY26: reported $0.41 per share against an estimate of $2.39
PFSI news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
PennyMac Mortgage Investment Trust Announces Date for Release of Third Quarter 2026 Results
- Press releasePRNewswire
Rosen Law Firm Encourages PennyMac Financial Services, Inc. Investors to Inquire About Securities Class Action Investigation - PFSI
- Press releaseNewsfile
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages PennyMac Financial Services, Inc. Investors to Inquire About Securities Class Action Investigation - PFSI
- Press releaseBusiness Wire
PennyMac Financial Services, Inc. Live with VantageScore 4.0 Across All Three Production Channels
- Press releaseNewsfile
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages PennyMac Financial Services, Inc. Investors to Inquire About Securities Class Action Investigation - PFSI
- Press releaseNewsfile
ROSEN, A LEADING LAW FIRM, Encourages PennyMac Financial Services, Inc. Investors to Inquire About Securities Class Action Investigation - PFSI
- Press releaseNewsfile
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages PennyMac Financial Services, Inc. Investors to Inquire About Securities Class Action Investigation - PFSI
Similar companies
Companies in the same industry as PennyMac Financial Services
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- FRTTFort Technology$0.7121+32.63%
- SHFSSHF Holdings$0.0899−4.36%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.